Today: 29 June 2026
Browse Category

ASX:NAB 16 January 2026 - 10 February 2026

NAB share price holds near A$44 as bank earnings loom and rate bets shift

NAB share price holds near A$44 as bank earnings loom and rate bets shift

National Australia Bank shares closed nearly flat at A$43.98 after a volatile session, ahead of its first-quarter trading update next week. NAB will raise variable home loan rates by 0.25% from Feb. 13, following the Reserve Bank’s latest hike. A NAB survey showed business cost pressures at their lowest since 2021. The bank also announced disaster relief for customers hit by Northern Territory flooding.
10 February 2026
···
Commonwealth Bank share price slides again as banks drag ASX; the next big dates for CBA stock

CBA shares pop after $68m ASIC provision—here’s what markets are watching before Feb 11

Commonwealth Bank shares rose 1.4% to A$159.28 after it disclosed a A$68 million pre-tax provision tied to an ASIC review and A$53 million in non-recurring income items. The update comes ahead of CBA’s half-year results and interim dividend announcement on Feb. 11, as investors weigh the impact of the Reserve Bank’s latest rate hike on mortgage costs.
5 February 2026
···
NAB share price jumps 2% after RBA hike — what traders watch next

NAB share price jumps 2% after RBA hike — what traders watch next

National Australia Bank shares rose 2.1% to A$43.93 Wednesday after the Reserve Bank of Australia lifted its cash rate by 25 basis points to 3.85%. Major banks, including NAB, announced matching increases to variable mortgage rates, their first such move in two years. Investors await the RBA’s meeting minutes on Feb. 17 and NAB’s trading update on Feb. 18.
4 February 2026
·····
Australia stock market today: ASX 200 jumps as RBA hikes rates and miners rebound

Australia stock market today: ASX 200 jumps as RBA hikes rates and miners rebound

The S&P/ASX 200 closed up 0.89% at 8,857.10 after the Reserve Bank of Australia raised its cash rate to 3.85%, the first hike in two years. Miners, tech, and banks led gains as investors adjusted to the new rate outlook. Major banks will lift variable home-loan rates by 25 basis points by mid-February. The index traded between 8,778.60 and 8,896.60 during the session.
3 February 2026
··········
NAB (ASX:NAB) share price jumps 3% — what to watch next for National Australia Bank stock

NAB (ASX:NAB) share price jumps 3% — what to watch next for National Australia Bank stock

NAB shares surged 3.04% to A$42.45 on Thursday after Australia reported a surprise gain of 65,200 jobs in December, sending the unemployment rate to 4.1%. The S&P/ASX 200 closed up 0.8%. Investors shifted rate expectations ahead of next week’s CPI data and the RBA’s February decision. NAB also warned of rising investment scams using fake identities on social media.
22 January 2026
·
NAB share price drops as ASX banks slide again — what to watch before Thursday’s open

NAB share price drops as ASX banks slide again — what to watch before Thursday’s open

National Australia Bank fell 1.62% to A$41.18 Wednesday, with 2.94 million shares traded, extending a recent slide in major Australian banks. The S&P/ASX 200 closed down 0.37%, pulled lower by financial stocks, while gold surged past $4,800 an ounce. Wall Street’s sharp drop and renewed tariff risks pressured local markets. NAB announced plans to close its Knox data centre and appointed Mahya Knox as chief AI officer.
21 January 2026
··
NAB share price drops again as trade jitters bite — what National Australia Bank investors watch next

NAB share price drops again as trade jitters bite — what National Australia Bank investors watch next

National Australia Bank shares fell 0.85% to A$41.86, their second straight decline, as about 1.23 million shares changed hands Tuesday. The S&P/ASX 200 closed down 0.66% at 8,815.9. NAB named Mahya Knox chief AI officer, while its Knox data centre closure will relocate at least 270 staff. Markets are watching Thursday’s jobs report and the Feb. 3 RBA meeting for rate signals.
20 January 2026
·
Westpac share price today: WBC slips as CEO equity awards land; traders eye tariff noise

Westpac share price today: WBC slips as CEO equity awards land; traders eye tariff noise

Westpac shares fell 0.98% to A$38.59 Tuesday, extending losses as the S&P/ASX 200 dropped 0.66%. Company filings showed CEO Anthony James Miller received 91,383 new share rights and acquired 18,967 shares on Jan. 13. Other top executives were also granted fresh share rights. Markets tracked U.S.-EU trade tensions and local rate signals ahead of Wednesday’s open.
20 January 2026
···
Australia mortgage shock: CBA and Macquarie lift fixed home loan rates ahead of RBA decision

Australia mortgage shock: CBA and Macquarie lift fixed home loan rates ahead of RBA decision

Commonwealth Bank of Australia raised fixed home loan rates by up to 0.70 percentage points, with its three-year fixed rate now at 6.04%. Macquarie Bank also increased fixed rates, while NAB currently offers the lowest big-four fixed rate at 5.39%. The Reserve Bank of Australia meets Feb. 2–3, following a key inflation report due Jan. 28. The RBA cash rate remains at 3.6%.
16 January 2026
···
NAB share price edges up as banks lift ASX into weekend; RBA and Q1 update in focus

NAB share price edges up as banks lift ASX into weekend; RBA and Q1 update in focus

NAB shares closed up 0.73% at A$42.67 Friday, leading gains among Australian banks as the S&P/ASX 200 rose 0.48% to 8,903.9. Traders are watching rate expectations ahead of the Reserve Bank’s Feb. 3 decision. UBS issued a pre-stabilisation notice for NAB’s planned euro subordinated notes. NAB’s housing report showed dwelling prices up 8.2% in 2025 and advertised rents rising 5.9% in December.
16 January 2026
·
1 2 3 4

Stock Market Today

  • Neurocrine Biosciences (NBIX) Gains as Strong Earnings Forecasts Boost Stock
    June 29, 2026, 5:49 AM EDT. Neurocrine Biosciences (NBIX) has emerged as a robust biotech performer with strong earnings momentum driven by its flagship treatment INGREZZA, which treats movement disorders. Analysts have sharply raised earnings per share (EPS) estimates for NBIX across upcoming quarters and fiscal years, reflecting increased confidence in the stock. INGREZZA's sales reached $2.86 billion in 2025, up 22% year-over-year, with projected growth continuing in 2026. The company also benefits from growing physician adoption and expanding patient awareness. Rising earnings forecasts, driven by strong operational performance and a broad consensus among analysts, have elevated NBIX to a Zacks Rank #1 (Strong Buy). Investors see Neurocrine's expanding portfolio and pipeline as key to sustaining growth beyond INGREZZA's success.

Latest articles

ServiceNow (NYSE:NOW) stock: $9 billion Friday jump puts contract base back in focus

ServiceNow (NYSE:NOW) stock: $9 billion Friday jump puts contract base back in focus

29 June 2026
ServiceNow (NYSE:NOW) surged 9.85% to $98.34 Friday, adding $9.1 billion in equity value—about 72% of its $12.64 billion Q1 current remaining performance obligations—as software stocks outperformed amid rotation out of AI names; the move comes ahead of a potential near-term bookings catalyst tied to price increases and legacy tier retirements, with short interest at 5.82% of float.
Nvidia holds $47 billion-per-point sway as Nasdaq tries for bounce

Nvidia holds $47 billion-per-point sway as Nasdaq tries for bounce

29 June 2026
Nvidia’s $4.7 trillion market value means every 1% stock move shifts $47 billion, putting massive index risk in focus as AI capex spending faces fresh scrutiny from new BIS data and rising China chip competition, with premarket gains tested by funding and substitution risks.
Microsoft rebound ahead of Nasdaq open puts AI spending in spotlight

Microsoft rebound ahead of Nasdaq open puts AI spending in spotlight

29 June 2026
Microsoft surged 5.7% to $372.97 in premarket trading, adding $149 billion in market value, as investors weigh soaring AI-driven capex—Q3 spending was about twice free cash flow—against strong cloud growth and a $37 billion AI revenue run rate, while analysts warn higher costs could pressure margins.
Go toTop